Menu
Not yet recruiting NCT06009289

Light and Sleep Fragmentation

Phase IV Interventional Sleep Mild Cognitive Impairment Mood Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Light therapy.
Who it may be relevant to
Registry conditions: Sleep, Mild Cognitive Impairment, Mood Disorders. Basic parameters: 65 years — 99 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Application of Precision Medicine to Phototherapy: a Stepped Care Approach to Consolidate Sleep and Slow Cognitive Decline in Older Adults

Overview

This trial will examine scheduled exposure to bright light in the morning and afternoon as a countermeasure to sleep fragmentation in older individuals with mild cognitive impairment.

Interventions

  • Behavioral Light therapy
    One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor

Primary outcome measures

  • Sleep fragmentation [Time frame: 4 weeks]
Secondary outcome measures (2)
  • Cognition [Time frame: 6 months]
  • Mood [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Mild Cognitive Impairment
  • Age >65

Exclusion criteria

  • Severe depression
  • Unstable psychiatric or medical disease
  • Acute infection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Sequential
Masking
Double blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Stanford University — Redwood City

Identifiers

NCT: NCT06009289 · IRB-71788

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗